Name: Latest research reports of Torrent Pharmaceuticals Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Torrent Pharmaceuticals Ltd.
Rating: 3
Author: Motilal Oswal

Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420 | ISIN: INE685A01028 | Industry: Pharmaceuticals
| Expensive Performer

3254.8000 32.10 (1.00%)

NSE Apr 17, 2025 15:31 PM

29.16% Gain from 52W Low

Volume: 202.3K

Torrent Pharmaceuticals Ltd.

23 Jul 2024

3254.80

1.00%

India/Germany businesses drive earnings

Neutral: Torrent Pharmaceuticals Ltd.

Target

Motilal Oswal

Torrent Pharma (TRP) delivered largely in-line 1QFY25. TRP posted robust 14.7% YoY growth in domestic formulation (DF) segment.

Torrent Pharmaceuticals Ltd.'s price crossed above 100Day SMA today